United Therapeutics Corp
UTHR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001082554
In the last 90 days, United Therapeutics Corp insiders filed 0 open-market purchases and 68 sales; 886 institutions reported holding it in 13F filings for Q2 2026, worth $22.6B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in United Therapeutics Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 512
- +62 vs. Q3 2022
- Shares held
- 44.8M
- +205.6K (+0.5%) vs. Q3 2022
- Total value
- $12.5B
- +$3.12B (+33.4%) vs. Q3 2022
- New holders
- 90
- 167 more added
- Sold out
- 28
- 177 more reduced
10 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UTHR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 886 | $22.6B |
| Q1 2026 | 854 | $24.6B |
| Q4 2025 | 837 | $20.3B |
| Q3 2025 | 708 | $17.2B |
| Q2 2025 | 671 | $12.6B |
| Q1 2025 | 672 | $13.8B |
| Q4 2024 | 673 | $15.6B |
| Q3 2024 | 626 | $15.7B |
| Q2 2024 | 568 | $14.6B |
| Q1 2024 | 524 | $10.4B |
| Q4 2023 | 536 | $9.85B |
| Q3 2023 | 510 | $10.1B |
| Q2 2023 | 475 | $9.94B |
| Q1 2023 | 507 | $10.1B |
| Q4 2022 | 512 | $12.5B |
| Q3 2022 | 460 | $9.35B |
| Q2 2022 | 474 | $10.4B |
| Q1 2022 | 427 | $7.91B |
| Q4 2021 | 416 | $9.34B |
| Q3 2021 | 426 | $8.17B |
| Q2 2021 | 403 | $7.81B |
| Q1 2021 | 392 | $7.30B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding United Therapeutics Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 655,873 | $182.4M | 1.18% | +106,200+19.3% | Added |
| Geode Capital Management, LLC | 660,876 | $183.8M | 0.03% | +29,137+4.6% | Added |
| Janus Henderson Group PLC | 767,426 | $213.4M | 0.15% | −57,395−7.0% | Reduced |
| Avidity Partners Management LP | 785,500 | $218.4M | 5.11% | −184,700−19.0% | Reduced |
| State Street Corp | 1,549,355 | $430.9M | 0.03% | −46,662−2.9% | Reduced |
| Renaissance Technologies LLC | 2,344,492 | $652.0M | 0.89% | −205,722−8.1% | Reduced |
| Wellington Management Group LLP | 2,569,263 | $714.5M | 0.14% | +1,212,497+89.4% | Added |
| FMR LLC | 2,586,804 | $719.4M | 0.07% | −390,455−13.1% | Reduced |
| Avoro Capital Advisors LLC | 2,865,000 | $796.7M | 11.91% | −61,500−2.1% | Reduced |
| Vanguard Group Inc | 4,480,719 | $1.25B | 0.03% | +69,103+1.6% | Added |
| BlackRock Inc. | 4,510,367 | $1.25B | 0.04% | +182,999+4.2% | Added |
| Transamerica Financial Advisors, Inc. | 1 | – | – | 00.0% | Unchanged |
| Proequities, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −89,979−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −68,190−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −52,611−100.0% | Sold out |
| Kiwi Wealth Investments Limited Partnership | 0 | $0 | 0.00% | −14,626−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −13,162−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −6,634−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −4,200−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −2,879−100.0% | Sold out |
| Echo Street Capital Management LLC | 0 | $0 | 0.00% | −2,604−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −2,377−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −2,188−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −2,075−100.0% | Sold out |
| Clal Insurance Enterprises Holdings Ltd | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −1,467−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −1,119−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,081−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −1,074−100.0% | Sold out |
| Chiron Investment Management, LLC | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −259−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| MUFG Americas Holdings Corp | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Hallmark Capital Management Inc | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Pittenger & Anderson Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Pinnacle Bancorp, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Eaton Vance Management | – | – | – | – | Not filed |
| Regentatlantic Capital LLC | – | – | – | – | Not filed |
| Balasa Dinverno & Foltz LLC | – | – | – | – | Not filed |
| Corient Capital Partners, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| New Century Advisors, LLC | – | – | – | – | Not filed |
| American Research & Management Co. | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |
| Covington Capital Management | – | – | – | – | Not filed |